HORIZON-HLTH-2021-DISEASE-04
HORIZON-HLTH-2021-DISEASE-04
- Programme
- HORIZON
- Funded projects (dataset)
- 39
- EU contribution (sum)
- €263,175,129
- Portal deadline
- —
Leading topic in historical projects: HORIZON-HLTH-2021-DISEASE-04-04
Start here
Suggested partners for this call
Who coordinated consortia under this call, plus a complementary slice (topic leaders, research partners, or frequent non-coordinators). For industry lists, CSV export, and consortium size — open Proposal partner finder.
Top coordinators
Organisations that coordinated the most funded projects under this call.
- INSERM2 coordinated
- OUS2 coordinated
- UNIPI2 coordinated
- UNIVERSITEIT MAASTRICHT2 coordinated
- AU1 coordinated
- Leiden University Medical Center1 coordinated
- AUEB-RC1 coordinated
- CHARITE - UNIVERSITAETSMEDIZIN BERLIN1 coordinated
- DZNE1 coordinated
- EATRIS1 coordinated
- RESEARCH UNIVERSITY INSTITUTE OF COMMUNICATION AND COMPUTER SYSTEMS1 coordinated
- EUROPEAN VACCINE INITIATIVE1 coordinated
Organisations strong on this topic
Broader signal: frequent participants across funded projects tagged with the same topic codes as this call (not limited to coordinators).
- KI7 topic projects
- ECPC6 topic projects
- UOA5 topic projects
- EUROPEAN ASSOCIATION FOR PALLIATIVE CARE5 topic projects
- UMC UTRECHT3 topic projects
- INT3 topic projects
- VHIR3 topic projects
- Casa Sperantei3 topic projects
- KU Leuven3 topic projects
- OSR3 topic projects
- REGIONH3 topic projects
- STICHTING AMSTERDAM UMC3 topic projects
Frequent collaborators
Pairs that often appear together in the same funded project under this call.
- 4 shared
- ECPC · Casa Sperantei3 shared
BE ↔ RO
- 3 shared
- 3 shared
- 2 shared
- 2 shared
- MINISTRY OF HEALTH · ZON2 shared
IT ↔ NL
- 2 shared
- DLR · MINISTRY OF HEALTH2 shared
DE ↔ IT
- CNR · ISTITUTO SUPERIORE DI SANITA2 shared
IT ↔ IT
- 2 shared
- 2 shared
- 2 shared
- 2 shared
- 2 shared
- 2 shared
- UNIVERSITEIT MAASTRICHT · TUM2 shared
NL ↔ DE
- 2 shared
Proposal partner finder
One page with suggested coordinators, strong and industry partners, topic leaders, typical consortium size, similar projects — plus CSV or print / PDF export for your shortlist.
Typical consortium pattern
Derived from historical funded projects linked to this CORDIS call in Grantibase.
- Avg. orgs / project
- 14.92
- Median orgs / project
- 14
- Min / max orgs
- 6 – 29
Country presence
Participant rows (an org can appear in multiple countries if data varies).
- Spain68
- Germany68
- Italy57
- France44
- Netherlands43
- United Kingdom38
- Belgium38
- Denmark25
- Sweden22
- Greece19
- Switzerland17
- Portugal16
- Norway12
- Poland10
- Austria9
- Romania8
- United States8
- Ireland7
Organization types
- university142 orgs · 205 rows
- research_institute125 orgs · 158 rows
- sme84 orgs · 87 rows
- public_body35 orgs · 46 rows
- other35 orgs · 44 rows
- company36 orgs · 42 rows
Topics in funded projects
- HORIZON-HLTH-2021-DISEASE-04-04HORIZON-HLTH-2021-DISEASE-04-04· 13 projects
- HORIZON-HLTH-2021-DISEASE-04-01HORIZON-HLTH-2021-DISEASE-04-01· 8 projects
- HORIZON-HLTH-2021-DISEASE-04-07HORIZON-HLTH-2021-DISEASE-04-07· 8 projects
- HORIZON-HLTH-2021-DISEASE-04-03HORIZON-HLTH-2021-DISEASE-04-03· 6 projects
- HORIZON-HLTH-2021-DISEASE-04-02HORIZON-HLTH-2021-DISEASE-04-02· 2 projects
- HORIZON-HLTH-2021-DISEASE-04-05HORIZON-HLTH-2021-DISEASE-04-05· 1 projects
- HORIZON-HLTH-2021-DISEASE-04-06HORIZON-HLTH-2021-DISEASE-04-06· 1 projects
Related funded projects
Largest EU contributions in this call — useful to see who already won funding on similar lines.
Open full project list in advanced search
| Project | Programme | EU contribution |
|---|---|---|
| REPO4EU Precision drug REPurpOsing For EUrope and the world | HORIZON | €22,982,612 |
| REMEDi4ALL BUILDING A SUSTAINABLE EUROPEAN INNOVATION PLATFORM TO ENHANCE THE REPURPOSING OF MEDICINES FOR ALL | HORIZON | €22,561,532 |
| ADVANCE-VAC4PM Advancing The Clinical Development Of Placental Malaria Vaccines In The Context Of Capacity Building and Use Of Digital Health Technologies | HORIZON | €9,999,995 |
| NEUROCOV The pandemic within: tackling brain vulnerability in COVID19 at high resolution: NEUROCOV | HORIZON | €8,384,036 |
| DUALSAVE-FGS Dual screening by Spectral Artificial Visual Examination (SAVE) for Female Genital Schistosomiasis (FGS) and cervical cancer. Digital, new, low-cost, and simple screening and training. | HORIZON | €7,984,441 |
| REACT Respiratory Host-Pathogen Interaction | HORIZON | €7,597,250 |
| PvSTATEM SEROLOGICAL TESTING AND TREATMENT FOR P. VIVAX: FROM A CLUSTER-RANDOMISED TRIAL IN ETHIOPIA AND MADAGASCAR TO A MOBILE-TECHNOLOGY SUPPORTED INTERVENTION | HORIZON | €7,290,778 |
| HORUS Casting light on HOst-cytomegaloviRUs interaction in Solid organ transplantation | HORIZON | €7,136,103 |
| EChiLiBRiST Development and validation of a quantitative point-of-care test for the measurement of severity biomarkers to improve risk stratification of fever syndromes and enhance child survival | HORIZON | €6,935,381 |
| EPIVINF Epigenetic regulation of host factors in viral infections (EPIVINF) | HORIZON | €6,932,308 |
| HERVCOV SARS-CoV-2-induced activation of pathogenic endogenous retrovirus envelope HERV-W: towards personalized treatment of COVID-19 patients | HORIZON | €6,846,157 |
| D-SOLVE Understanding the individual host response against Hepatitis D Virus to develop a personalized approach for the management of hepatitis D | HORIZON | €6,754,010 |
| UNDINE The human genetic and immunological determinants of the clinical manifestations of SARS-CoV-2 infection: Towards personalised medicine | HORIZON | €6,718,139 |
| Long Covid Decision support for prediction and management of Long Covid Syndrome (LCS) | HORIZON | €6,549,674 |
| AInCP clinical validation of Artificial Intelligence for providing a personalized motor clinical profile assessment and rehabilitation of upper limb in children with unilateral Cerebral Palsy | HORIZON | €6,494,092 |
